Provenance du réseau au premier degré de Jaime Mayor de Juan
Entité | Type d'entité | Industrie | |
---|---|---|---|
Artá Capital SGEIC SA
Artá Capital SGEIC SA Investment ManagersFinance Artá Capital SGEIC SA (Artá Capital) is a private equity arm of Artá Partners SA founded in 2007. The firm is headquartered in Madrid, Spain.
3
| Private Company | Investment Managers | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jaime Mayor de Juan via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Dreamers Factory Innovacion Outpost SL
Dreamers Factory Innovacion Outpost SL Investment ManagersFinance Dreamers Factory Innovacion Outpost SL (Dreamers Factory) is a venture capital firm founded in 2019 by Jose Antonio Borge, Eneko Knörr and Gorka Fius. The firm is headquartered in Spain with an additional office in the US. | Investment Managers | Founder | |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Executive Officer | |
Chimeron Bio Corp.
Chimeron Bio Corp. Medical SpecialtiesHealth Technology Chimeron Bio Corp. is a biotechnology company based in the USA that is focused on developing a pipeline of products in oncology, rare genetic disorders, and infectious diseases using its proprietary chaesar™ platform. The American company is researching self-amplifying RNA (sRNA) to develop novel RNA drugs and vaccines for various diseases. Chimeron Bio is combining a first-in-class platform and the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics. The company was founded by Jolly Mazumdar, and the CEO is Kevin J. Heyeck. | Medical Specialties | Director/Board Member | |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
University of Navarra | College/University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Espagne | 3 |
Sectorielle
Finance | 3 |
Health Technology | 3 |
Consumer Services | 2 |
Opérationnelle
Private Equity Analyst | 2 |
Founder | 2 |
Director/Board Member | 2 |
Private Equity Investor | 1 |
Chief Executive Officer | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Jaime Mayor de Juan
- Connexions Sociétés